Nghia Trung Bui, Thau Manh Cao, Anh Gia Pham, Son Hong Trinh, Trang Thi Huyen Vo, Hang Thi Thu Nguyen, Tung Thanh Pham, Lam Thanh Phan, Hang Thu Nong, Ngoc Thi Tran, Cong Tien Bui
{"title":"Prognostic Determinants of Disease-Free Survival After Curative Resection for Hepatocellular Carcinoma: A Retrospective Cohort Study.","authors":"Nghia Trung Bui, Thau Manh Cao, Anh Gia Pham, Son Hong Trinh, Trang Thi Huyen Vo, Hang Thi Thu Nguyen, Tung Thanh Pham, Lam Thanh Phan, Hang Thu Nong, Ngoc Thi Tran, Cong Tien Bui","doi":"10.2147/CMAR.S620097","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Hepatocellular carcinoma (HCC) is one of the three leading causes of cancer death worldwide today. It is most common in Asia. Liver resection is a curative treatment in the early stages. However, postoperative prognosis varies and data in Southeast Asia are still limited.</p><p><strong>Methods: </strong>This retrospective descriptive study included 295 patients with hepatocellular carcinoma who underwent curative intent resection at Viet Duc University Hospital between January 2015 and December 2024. Disease-free survival (DFS) was analyzed using the Kaplan-Meier method and compared with the Log rank test. Univariate and multivariate Cox proportional hazards regression analyses were performed to identify prognostic factors. A nomogram integrating clinical and imaging features was constructed and evaluated using receiver operating characteristic (ROC) curves, calibration plots, and decision curve analysis (DCA).</p><p><strong>Results: </strong>The median follow-up duration was 60.4 months (1-128 months). The DFS was 35.6 months. Multivariate analysis identified advanced TNM stage (III-IV) (HR 2.562, 95% CI 1.605-4.091, p<0.001), presence of microvascular invasion (HR 1.773, 95% CI 1.295-2.429, p<0.001), positive resection margin (R1) (HR 2.254, 95% CI 1.318-3.857, p=0.003) as independent predictors of poorer DFS, and Child-Pugh B (HR 2.319, 95% CI 1.234-4.356, p=0.009). A prognostic nomogram constructed from these tumor-related factors achieved a concordance index (C-index) of 0.64 (95% CI: 0.60-0.68). Time-dependent ROC analysis demonstrated area under the curve (AUC) values of 0.698, 0.678, and 0.682 at 1, 3, and 5 years, respectively, reflecting acceptable predictive accuracy and favorable calibration.</p><p><strong>Conclusion: </strong>Advanced tumor stage, microvascular invasion, and positive resection margins are key determinants of disease-free survival after curative resection for hepatocellular carcinoma. A nomogram derived from Vietnamese real-world data may facilitate individualized postoperative risk stratification and surveillance strategies.</p>","PeriodicalId":9479,"journal":{"name":"Cancer Management and Research","volume":"18 ","pages":"620097"},"PeriodicalIF":2.6000,"publicationDate":"2026-08-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13469314/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer Management and Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/CMAR.S620097","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: Hepatocellular carcinoma (HCC) is one of the three leading causes of cancer death worldwide today. It is most common in Asia. Liver resection is a curative treatment in the early stages. However, postoperative prognosis varies and data in Southeast Asia are still limited.
Methods: This retrospective descriptive study included 295 patients with hepatocellular carcinoma who underwent curative intent resection at Viet Duc University Hospital between January 2015 and December 2024. Disease-free survival (DFS) was analyzed using the Kaplan-Meier method and compared with the Log rank test. Univariate and multivariate Cox proportional hazards regression analyses were performed to identify prognostic factors. A nomogram integrating clinical and imaging features was constructed and evaluated using receiver operating characteristic (ROC) curves, calibration plots, and decision curve analysis (DCA).
Results: The median follow-up duration was 60.4 months (1-128 months). The DFS was 35.6 months. Multivariate analysis identified advanced TNM stage (III-IV) (HR 2.562, 95% CI 1.605-4.091, p<0.001), presence of microvascular invasion (HR 1.773, 95% CI 1.295-2.429, p<0.001), positive resection margin (R1) (HR 2.254, 95% CI 1.318-3.857, p=0.003) as independent predictors of poorer DFS, and Child-Pugh B (HR 2.319, 95% CI 1.234-4.356, p=0.009). A prognostic nomogram constructed from these tumor-related factors achieved a concordance index (C-index) of 0.64 (95% CI: 0.60-0.68). Time-dependent ROC analysis demonstrated area under the curve (AUC) values of 0.698, 0.678, and 0.682 at 1, 3, and 5 years, respectively, reflecting acceptable predictive accuracy and favorable calibration.
Conclusion: Advanced tumor stage, microvascular invasion, and positive resection margins are key determinants of disease-free survival after curative resection for hepatocellular carcinoma. A nomogram derived from Vietnamese real-world data may facilitate individualized postoperative risk stratification and surveillance strategies.
期刊介绍:
Cancer Management and Research is an international, peer reviewed, open access journal focusing on cancer research and the optimal use of preventative and integrated treatment interventions to achieve improved outcomes, enhanced survival, and quality of life for cancer patients. Specific topics covered in the journal include:
◦Epidemiology, detection and screening
◦Cellular research and biomarkers
◦Identification of biotargets and agents with novel mechanisms of action
◦Optimal clinical use of existing anticancer agents, including combination therapies
◦Radiation and surgery
◦Palliative care
◦Patient adherence, quality of life, satisfaction
The journal welcomes submitted papers covering original research, basic science, clinical & epidemiological studies, reviews & evaluations, guidelines, expert opinion and commentary, and case series that shed novel insights on a disease or disease subtype.